Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 12:33PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.87B |
| Enterprise Value | 2.77B |
| Trailing P/E | 478.56 |
| Forward P/E | 111.11 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.65 |
| Price/Book (mrq) | 17.90 |
| Enterprise Value/Revenue | 15.24 |
| Enterprise Value/EBITDA | -10.31 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.72 |
| 52-Week Change 3 | -42.15% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 42.48 |
| 52 Week Low 3 | 20.67 |
| 50-Day Moving Average 3 | 27.61 |
| 200-Day Moving Average 3 | 28.85 |
Share Statistics
| Avg Vol (3 month) 3 | 1.29M |
| Avg Vol (10 day) 3 | 964.74k |
| Shares Outstanding 5 | 123.9M |
| Implied Shares Outstanding 6 | 123.9M |
| Float 8 | 118.95M |
| % Held by Insiders 1 | 4.49% |
| % Held by Institutions 1 | 67.26% |
| Shares Short (Apr 15, 2024) 4 | 8.87M |
| Short Ratio (Apr 15, 2024) 4 | 9.26 |
| Short % of Float (Apr 15, 2024) 4 | 8.40% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 7.16% |
| Shares Short (prior month Mar 15, 2024) 4 | 9.2M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Nov 17, 2011 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Sept 30, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -163.32% |
| Operating Margin (ttm) | -3,845.25% |
Management Effectiveness
| Return on Assets (ttm) | -24.66% |
| Return on Equity (ttm) | -106.24% |
Income Statement
| Revenue (ttm) | 181.74M |
| Revenue Per Share (ttm) | 1.70 |
| Quarterly Revenue Growth (yoy) | -94.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -285.35M |
| Net Income Avi to Common (ttm) | -296.81M |
| Diluted EPS (ttm) | -2.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 213.38M |
| Total Cash Per Share (mrq) | 1.72 |
| Total Debt (mrq) | 392.27M |
| Total Debt/Equity (mrq) | 225.81% |
| Current Ratio (mrq) | 3.73 |
| Book Value Per Share (mrq) | 1.49 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -196.21M |
| Levered Free Cash Flow (ttm) | -317.24M |
© 2024 Yahoo. All rights reserved.